Moreover, CDKN2A/B is one of the criteria to diagnose High-grade astrocytoma with piloid features alongside a piloid cytology, frequent MAPK pathway gene alterations, loss of ATRX nuclear expression, and a distinct DNA methylation pattern [19]. This evidence concerns the gene ATRX and astrocytoma (excluding glioblastoma).